Sanofi will acquire Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders.
Sanofi hosted a conference call & webcast on the acquisition for the financial community.
!-- notag -->!-- notag -->!-- notag -->
Sanofi will acquire Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders.
Sanofi hosted a conference call & webcast on the acquisition for the financial community.